Skip to main content
. 2009 Mar 23;53(6):2382–2391. doi: 10.1128/AAC.00329-09

FIG. 3.

FIG. 3.

Expression of galactomannan antigenemia in persistently neutropenic rabbits with pulmonary aspergillosis treated with anidulafungin at 5 (AFG5) (n = 6), anidulafungin at 10 mg/kg/day (AFG10) (n = 8), voriconazole at 10 mg/kg q8h (VRC) (n = 10), anidulafungin-voriconazole combinations (AFG5+VRC (n = 7) and AFG10+VRC (n = 8)), and untreared controls (Control) (n = 12). Animals treated with the AFG5+VRC combination and VRC alone had significantly lower levels of galactomannan antigenemia in comparison to all other groups (*, P ≤ 0.05).